Status:
COMPLETED
Safety and Efficacy Extension Study of Iron Isomaltoside 1000 (Monofer®) in Subjects With Inflammatory Bowel Disease
Lead Sponsor:
Pharmacosmos A/S
Conditions:
Inflammatory Bowel Disease
Anaemia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Since the duration of most studies with IV iron in IBD subjects have been only 4-12 weeks studies there is a need to follow-up on long term safety and efficacy of any maintenance iron therapy. This s...
Eligibility Criteria
Inclusion
- Completed the Lead-in Study or discontinued from Lead-in Study due to intolerance to oral iron.
- Life expectancy beyond 18 months by Investigator's judgement.
- Willingness to participate after informed consent. -
Exclusion
- Discontinuation from Lead-in Study (except for due to intolerance to oral therapy).
- Any major protocol deviation in Lead-in Study.
- Pregnancy and nursing \[To avoid pregnancy, women have to be postmenopausal, surgically sterile, or women of child bearing potential must use one of the following contraceptives during the whole study period and after the study has ended for at least 5 times plasma biological half-life of the investigational medicinal product (5 days): Contraceptive pills, Intrauterine Devices (IUD), contraceptive injections (prolonged-release gestagen), subdermal implantation, vaginal ring, and transdermal patches\].
- Any other medical condition that, in the opinion of Investigator, may cause the subject to be unsuitable for the completion of the study or place the subject at potential risk from being in the study.
- Patients with a Harvey-Bradshaw Index \>8 or Partial Mayo Score (excluding Endoscopy Sub-score) \>6 at End of Study Visit of Lead-in Study.
- \-
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT01410435
Start Date
June 1 2011
End Date
September 1 2013
Last Update
November 26 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Austria
Austria, Austria
2
Hungary
Hungary, Hungary